Acquiring Company
Novartis
Acquired Company
DTx Pharma, Inc.
Switzerland
San DiegoBiotechnologyHealth CarepharmaceuticalsBiotechnologyHealthcareHealth CareTherapeuticsDescription
DTx Pharma, a preclinical stage biotechnology company addressing the delivery challenges of oligonucleotide therapeutics with its Fatty Acid Ligand Conjugated OligoNucleotide (FALCONTM) platform, announced today that it has been acquired by Novartis. The FALCON platform enables the delivery and activity of small interfering RNA (siRNA) therapeutics to tissues beyond the liver, enhancing biodistribution and cellular uptake. DTx Pharma's lead program is currently in preclinical development, with FDA Orphan Drug Designation, for the treatment of Charcot-Marie-Tooth Disease Type 1A (CMT1A). CMT1A is a progressive, neuromuscular, autosomal-dominant disease that can lead to life-long loss of muscle function and disability.
Quick answer
Novartis is acquiring DTx Pharma, Inc., announced July 17, 2023. Novartis is based in Switzerland.
- Who acquired DTx Pharma, Inc?
- Novartis agreed to acquire DTx Pharma, Inc. on July 17, 2023.
- How much did Novartis pay for DTx Pharma, Inc?
- The deal value was not disclosed.
- What does Novartis do?
- Novartis AG is a Swiss multinational pharmaceutical company headquartered in Basel.
- Where are Novartis and DTx Pharma, Inc. based?
- Novartis is based in Switzerland. DTx Pharma, Inc. is based in San Diego, California, United States.
- Who are the decision-makers at Novartis?
- Fundz holds 1 contact at Novartis. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in pharmaceuticals and Healthcare
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Regeneron To Acquire Decibel Therapeutics, Strengthening Gene Therapy And Hearing Loss Programs (August 9, 2023)
- Revolution Medicines, Inc. To Acquire Eqrx, Inc. In All-Stock Transaction To Gain More Than $1 Billion In Additional Capital, $1B (August 1, 2023)
- Cybin To Acquire Small Pharma Inc. (August 28, 2023)
- Lilly Completes Acquisition Of Dice Therapeutics (August 9, 2023)
- Ikena Oncology Acquires Pionyr Immunotherapeutics In All-Stock Transaction (August 7, 2023)
- Lilly To Acquire Versanis To Improve Patient Outcomes In Cardiometabolic Diseases (July 14, 2023)
Who to call at Novartis, and when
When Novartis changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Novartis raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Novartis, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Novartis. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Novartis makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired DTx Pharma, Inc.?
DTx Pharma, Inc. was acquired by Novartis, based in Switzerland. The deal was reported on July 17, 2023. Novartis AG is a Swiss multinational pharmaceutical company headquartered in Basel. Novartis is publicly traded (NVS) and operates in Biotechnology.
When did Novartis acquire DTx Pharma, Inc.?
Novartis's acquisition of DTx Pharma, Inc. was reported on July 17, 2023. DTx Pharma, a preclinical stage biotechnology company addressing the delivery challenges of oligonucleotide therapeutics with its Fatty Acid Ligand Conjugated OligoNucleotide (FALCONTM) platform, announced today that it has been acquired by Novartis. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does DTx Pharma, Inc. do?
DTx Pharma, Inc. It is privately held, operating in Biotechnology, and is based in San Diego.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.